Outset Medical Rebecca Chambers. Dr. Neil J. Campbell has more than 35 years of successful experience with public and private companies in the life sciences, medical, health tech, nanotechnology, artificial intelligence, and high-performance computing technologies. It is a rare opportunity to join a team passionate about transforming a stagnant, but rapidly growing market with a huge unmet patient need,” said Chambers. New CEO of Aethlon Medical: Brings to the Table Experience In Financing, Structuring Corporate Deals, Clinical Development and Regulatory Strategy, Brad Hauser Appointed President and CEO of Soliton, Imperative Care Appoints COO Daniel Davis as President and Member of Board of Directors, Erik Waldorff, PhD Appointed New Director of Science & Innovation of Telos Partners, UNION Therapeutics Strengthens Leadership Team With New Executive Appointments, Synklino ApS Appoints Tolga Hassan as CFO and Dr. Josefin-Beate Holz as CMO, Zynex Reports Neil Friery Appointed President and COO of Monitoring Solutions Division, Experienced Medical Device Executives Charlie Huiner and Mitch Levinson Added to Recros Medica BOD, Nick Welham Named Hygieia Chief Operating fficer, Distinguished and Impressive Executive Stuart F. Simpson Is Appointed Executive Chairman of Breg – Offers 25 Plus Years of Device Leadership Experience. concluded Dr. Toft-Kehler. Advertising Contact: advmdn@infomeddnews.com, © Copyright 2020 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. Medical Device News Magazine uses cookies to constantly improve our internet content and to create internal assessments pursuant to our data protection guidelines. "Nick Welham joins Hygieia as we grow and add to our capabilities,” said Eran Bashan, Ph.D., CEO, and co-founder of Hygieia. Rebecca Chambers joined Outset as Chief Financial Officer in June 2019. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Huiner is an experienced executive in the aesthetic medical device sector, having worked as a senior executive at Inamed, Isologen, and Sientra among others. This website uses cookies so that we can provide you with the best user experience possible. Rebecca Chambers Chief Financial Officer Rebecca Chambers joined Outset as Chief Financial Officer in June 2019. 3052 Orchard Drive An experienced CEO and business development advisor, Hussain’s expertise includes product strategy, marketing, operations management, investor relations, and customer onboarding and retention. If you disable this cookie, we will not be able to save your preferences. Maxwell will be based in Boston and London and will be responsible for all aspects of the Company’s financial strategy, management, and operations including ensuring that the Company is adequately financed to meet its ambitious growth plans. We are excited to welcome him to the team.”. “Rebecca’s deep capital markets expertise and growth-company track record is ideally suited to our stage of commercial expansion,” said Leslie Trigg, Outset’s Chief Executive Officer. Jim Hinrichs has 30 years of financial leadership experience in large and small organizations within the healthcare industry. Prior to Illumina, she led IR and corporate communications at Myriad Genetics, a molecular diagnostics company in Salt Lake City, Utah, as well as various roles at Life Technologies, now part of Thermo Fisher Scientific, Bank of America Merrill Lynch, and Millennium Pharmaceuticals, now Takeda Pharmaceuticals. With real-time water purification and dialysis fluid production integrated in a single, compact system, Tablo functions like a dialysis clinic on wheels. © 2020 Outset Medical, Inc. All rights reserved. “He brings to the team critical skills in continuous improvement, change management and digital transformation. It is a rare opportunity to join a team passionate about transforming a stagnant, but rapidly growing market with a huge unmet patient need,” said Chambers.

Rebecca Chambers “I am honored to be a part of Outset at this time in its growth trajectory. San Jose, CA 95134. * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). Rebecca Chambers Chief Financial Officer Rebecca brings to Outset Medical a wealth of experience in finance including investor relations, treasury, and financial planning and analysis. She has a wealth of experience across finance functions including investor relations, treasury, and financial planning and analysis. “We recognized in Rebecca a best-in-class ability to build a strong financial foundation and effective, transparent relationships with the investment community. Dr. Monica Bertagnolli is currently Professor of Surgery at Harvard Medical School and Associate Surgeon in the Division of Surgical Oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. Rebecca Chambers has been appointed Chief Financial Officer of Outset Medical. Yamamoto brings nearly 20 years of experience in mergers & acquisitions and business development. "Altogether, these additions to our team are important to ensure continued expansion and the ability to deliver on the ambitious goals set forth by the Board and owners of UNION, with the overarching vision of advancing medicine by listening and responding to patient needs." Contact us: mdnewsmagazine@infomeddnews.com, Learn how Medical Device News Magazine can help promote your medical devices. Dillon is a former St. Jude Medical and Abiomed executive, with significant experience capitalizing and commercializing first-in-class heart failure and cardiorenal syndrome technologies. Outset Medical is a commercial-stage company that delivers state-of-the-art technology to the growing global dialysis market. Former Illumina Executive Rebecca Chambers Joins Outset as Company Scales to Meet Demand. In addition, she held roles of increasing responsibility at companies including Myriad Genetics, Life Technologies, Bank of America Merrill Lynch, and Millennium Pharmaceuticals. Feldman will be responsible for forging and maintaining relationships with pharmaceutical manufacturers to coincide with Soleo Health’s expertise and focus on caring for complex specialty patients with rare and ultra-rare diseases. Rebecca joined the company from Illumina where she most recently served as Vice President of Finance. Rebecca brings to Outset Medical a wealth of experience in finance including investor relations, treasury, and financial planning and analysis. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. He will serve as Director, Science & Innovation, and will lead the Telos scientific services to lay the foundations of evidence necessary to meet medical device and biotechnology commercialization objectives.

Over the course of her career at Illumina, Rebecca Chambers led numerous financial functions including treasury, clinical financial planning and analysis and investor relations (IR). Neil will lead operations, sales, marketing and product development of the Monitoring Solution Division. November 23, 2020 Lifecare AS announced it has enhanced its Board of Directors (BOD) after an extraordinary general meeting Friday 20 November 2020. VectivBio Chief Executive Officer Luca Santarelli, MD said, "We are truly fortunate to have Sarah and Aditya on our team. Gordon has 20 years of experience in the life science tools market and has held senior positions at ForteBio, Phasefocus, and Unchained Labs. Previously, she held roles of increasing responsibility at companies including Myriad Genetics, Life Technologies, Bank of America Merrill Lynch, and Millennium Pharmaceuticals. She joins the company from Illumina where she was most recently the Vice President of Finance. This announcement follows the recent closing of a financing round led by Eir Ventures and Vaekstfonden. Wireless data, sensor-based automati. Rebecca Chambers has been named chief financial officer at Outset Medical , according to a press release.

Previously, she held roles of […] She joins the company from Illumina where she was most recently the Vice President of Finance. /s/ LeeAnn Linck, attorney-in-fact for Rebecca Chambers: 09/14/2020 ** Signature of Reporting Person: Date: Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Save my name, email, and website in this browser for the next time I comment. Tablo was designed to look and feel like an intuitive consumer product, keeping end-user simplicity in mind. A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE & INVESTOR, Omar Hussain 30 Year Proven Leadership in the Healthcare Data Security Industry Is Appointed to Secure AI Labs Board of Directors, Alastair Maxwell New CFO of Signifier Medical Technologies: Prestigious 30+ Years of Investment Banking Industry Experience, Rick Gordon Named Halo Labs CEO – Proven 20 Year Track Record, Lifecare AS Enhances Board of Impressive Directors, Laura Niklason MD, Ph.D Appointed Humacyte President & Chief Executive Officer: Involved In All Aspects of Growth Including Scientific Innovation & Development, Financing, Clinical Trials and More, Dr. Monica Bertagnolli Appointed to Natera BOD: Noted Experienced Oncology Researcher, Chris Yamamoto Appointed Bioventus Senior VP of Business Development & Strategy: Offers 20 + Years of Mergers & Acquisition Business Development, Amir Boloor Is Appointed Board Chair of Convalon: Impressive Track Record in Accelerating Growth, Jim Hinrichs Appointed to Signifier Medical Technologies Board of Directors- Provides 30+ Years of Financial Leadership and Governance Skills, Dr Rafael Grossmann Joins FundamentalVR Global Medical Panel: Thought Leader and Pioneering Healthcare and Education Futurist, Elizabeth Feldman Appointed Soleo Health VP Development, Industry Relations: Charged with Forging and Maintaining Pharma Manufacturer Relationships, Dr. Neil J. Campbell Is Appointed Marizyme CEO, President and Member of Board of Directors, Lisa Rose Named Chief Marketing Officer of LifeScan, Jim Dillon Joins FAST BioMedical Board of Directors: Provides Significant Commercialization Experience, Charles J. Fisher, Jr., M.D. Tablo was specifically designed to reduce the cost and complexity of dialysis, while improving the experience for patients and providers. Amir Boloor, an independent director of the Company, is also Chair of the Company's recently announced Special Committee, appointed to explore and evaluate a range of strategic alternatives available to the Company in order to enhance shareholder value. We use cookies to personalize content and ads, to provide social media features and to analyze our traffic.